Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	521	157	29	35	62	61
Market Cap Growth	306.60%	434.24%	-16.81%	-42.59%	1.75%	-25.71%
Enterprise Value	524	159	27	31	61	76
Last Close Price	0.49	0.15	0.03	0.03	0.06	0.07
PE Ratio	-	7.81	8.26	3.97	12.10	-
PS Ratio	7.35	2.77	0.86	1.10	2.43	3.36
PB Ratio	14.29	2.73	1.02	1.40	3.81	5.68
P/TBV Ratio	15.99	2.74	1.03	1.43	3.92	-
P/FCF Ratio	120.65	-	-	5.88	21.50	-
P/OCF Ratio	103.39	-	8.81	5.43	19.27	-
EV/Sales Ratio	7.48	2.81	0.80	0.96	2.40	4.25
EV/EBITDA Ratio	36.33	13.14	5.25	4.94	17.86	-
EV/EBIT Ratio	43.01	14.75	6.92	6.11	28.90	-
EV/FCF Ratio	121.34	-	-	5.15	21.24	-
Debt / Equity Ratio	0.31	0.20	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.78	0.96	0.73	0.43	0.66	-
Debt / FCF Ratio	2.61	-	-	0.46	0.83	-
Asset Turnover	0.85	0.91	0.90	1.05	0.99	0.73
Inventory Turnover	2.27	2.69	2.16	2.97	2.95	2.31
Quick Ratio	1.82	2.04	1.39	1.73	1.15	0.61
Current Ratio	3.27	3.07	2.75	2.82	2.10	1.19
Return on Equity (ROE)	-43.41%	46.47%	13.15%	43.01%	37.96%	-20.32%
Return on Assets (ROA)	9.20%	10.83%	6.52%	10.33%	5.14%	-5.79%
Return on Capital (ROIC)	14.92%	13.20%	8.15%	13.62%	7.92%	-9.50%
Return on Capital Employed (ROCE)	16.01%	15.28%	12.00%	17.82%	10.33%	-
Earnings Yield	-3.45%	12.80%	12.11%	25.18%	8.27%	-3.70%
FCF Yield	0.83%	-2.60%	-8.16%	17.00%	4.65%	-3.02%
Buyback Yield / Dilution	-3.71%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%
Total Shareholder Return	-3.71%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%

Source: S&P Capital IQ. Standard template. Financial Sources.